Cigna Investments Inc Abb Vie Inc. Transaction History

Cigna Investments Inc

$568 Million
Q3 2024

A detailed history of Cigna Investments Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cigna Investments Inc holds 18,297 shares of ABBV stock, worth $3.21 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

18,297

Previous 18,479 0.98%

Holding current value

$3.21 Million

Previous $3.17 Million 14.04%

% of portfolio

0.64%

Previous 0.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $29,818 - $36,278	-182 Reduced 0.98%	18,297 $3.61 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $34,827 - $40,671	-225 Reduced 1.2%	18,479 $3.17 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $20,297 - $23,126	-127 Reduced 0.67%	18,704 $3.41 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $9,907 - $11,157	-72 Reduced 0.38%	18,831 $2.92 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $331,036 - $383,222	-2,478 Reduced 11.59%	18,903 $2.82 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $14,973 - $18,633	-113 Reduced 0.53%	21,381 $2.88 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $56,831 - $65,450	-393 Reduced 1.8%	21,494 $3.43 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $14,107 - $16,918	102 Added 0.47%	21,887 $3.54 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $144,678 - $165,936	-1,078 Reduced 4.72%	21,785 $2.92 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.15 Million - $1.46 Million	-8,353 Reduced 26.76%	22,863 $3.5 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.18 Million - $1.47 Million	-8,950 Reduced 22.28%	31,216 $5.06 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1.51 Million - $1.91 Million	-14,088 Reduced 25.97%	40,166 $5.44 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $109,592 - $124,403	-1,030 Reduced 1.86%	54,254 $5.85 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $873,348 - $972,960	-8,301 Reduced 13.05%	55,284 $6.23 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $181,787 - $200,125	1,777 Added 2.88%	63,585 $6.88 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $387,317 - $522,920	4,812 Added 8.44%	61,808 $6.62 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $706,180 - $828,822	-8,220 Reduced 12.6%	56,996 $4.99 Million
Q2 2020 Aug 17, 2020	BUY	$73.37 - $98.18 $1.63 Million - $2.18 Million	22,215 Added 51.66%	65,216 $6.4 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $246,132 - $373,166	3,816 Added 9.74%	43,001 $3.28 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $301,503 - $377,245	-4,180 Reduced 9.64%	39,185 $3.17 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $279,001 - $335,439	-4,430 Reduced 9.27%	43,365 $3.45 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $4,139 - $5,290	-63 Reduced 0.13%	47,795 $3.19 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $6,479 - $7,626	84 Added 0.18%	47,858 $3.86 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $52,937 - $65,286	680 Added 1.44%	47,774 $4.4 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $1.74 Million - $1.93 Million	-19,565 Reduced 29.35%	47,094 $3.67 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $841,777 - $996,012	-9,376 Reduced 12.33%	66,659 $6.18 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $287,163 - $384,538	3,121 Added 4.28%	76,035 $7.2 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $206,256 - $226,177	-2,303 Reduced 3.06%	72,914 $7.05 Million
Q3 2017 Oct 11, 2017	BUY	$69.85 - $89.22 $5.25 Million - $6.71 Million	75,217	75,217 $6.68 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.

Account

Cigna Investments Inc Abb Vie Inc. Transaction History